Jakarta (ANTARA) - The Developing Countries Vaccine Manufacturers Network (DCVMN) called on collective action in addressing the global vaccine challenge.

The statement was delivered by DCVMN CEO Rajinder Suri when closing the 26th Developing Countries Vaccine Manufacturers Network (DCVMN) Annual General Meeting (AGM) 2025 in Denpasar, Bali from October 29–31.

"As Minister of Health, Budi Gunadi Sadikin mentioned, strengthening regional manufacturers to be closer to markets and create long term, sustainable value is essential. These words mark a moment filled with opportunities for bold action and new partnerships," Suri said during the closing session on Friday (Oct 31).

As the host of the event, PT Bio Farma (Persero) served as the co-host of this prestigious annual forum.

The event opened with remarks from several key figures, including DCVMN CEO Rajinder Suri, DCVMN Board Chair Adriansjah Azhari, Bio Farma President Director Shadiq Akasya, Indonesian Minister of Health Budi Gunadi Sadikin, and Vice Minister of Health Dante Saksono Harbuwono, then followed with a ceremonial gong.

The meeting featured a series of in-depth sessions covering critical topics, including vaccine financing, supply, and technological innovation.

Besides emphasizing the importance of collective action, Rajinder also expressed gratitude to Bio Farma as the co-host of the 26th AGM, acknowledging Shadiq Akasya and the team for their exceptional hospitality and professionalism throughout the event.

During the same session, delegates and members of DCVMN elected the new Board Chair for the 2026–2029 term.

Director of Human Capital at Bio Farma Iin Susanti was appointed as the third representative from Indonesia to serve on the DCVMN Board, following Mahendra Suhardono and Adriansjah Azhari.

"I am pleased to share that on the first day of the meeting, a new DCVMN Board Chair was elected. I am delighted to announce that In Susanti has been elected and will officially begin her term on January 1, 2026," he said.

Suri then invited all those who contributed to the success of the AGM, including panelists, Bio Farma representatives, DCVMN teams, and behind-the-scenes staff, to be acknowledged for their dedication.

He also announced that Beijing, China, will host the next DCVMN AGM, continuing the spirit of collaboration exemplified by Bio Farma’s leadership in Bali.

Related news: Bio Farma seeks public health protection, industrial sustainability

Related news: Bio Farma strengthens global vaccine development through DCVMN